Gilead and Galapagos Announce TORTUGA Phase 2 Study of Filgotinib in Ankylosing Spondylitis Achieves Primary Endpoint
FOSTER CITY, Calif. & MECHELEN, Belgium--(BUSINESS WIRE)--Sep. 6, 2018-- Gilead Sciences, Inc. (NASDAQ:GILD) and Galapagos...
Health News 2 me
healthnews2me.com
Tag: Galapagos